Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11.06.23 | Intellia Therapeutics, Inc.: Intellia Therapeutics Announces New Positive Clinical Data from Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Genome Editing Treatment for Hereditary Angioedema (HAE) | 325 | GlobeNewswire (Europe) | Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Across all patients (n=10), a single dose of NTLA-2002 led to a... ► Artikel lesen | |
11.06.23 | Kura Oncology, Inc.: Kura Oncology Presents Late-Breaking Clinical Data for Menin Inhibitor Ziftomenib at 2023 European Hematology Association (EHA) Congress | 274 | GlobeNewswire (Europe) | - 35% CR rate (7/20) among patients with relapsed/refractory NPM1-mutant AML treated at 600 mg dose (RP2D) - - 33% (2/6) of patients with FLT3 co-mutations and 50% (4/8) of patients with IDH co-mutations... ► Artikel lesen | |
11.06.23 | Ocular Therapeutix, Inc.: Ocular Therapeutix Announces 12-Month Topline Data from Ongoing U.S.-Based Phase 1 Clinical Trial Evaluating OTX-TKI for Treatment of Wet AMD | 493 | GlobeNewswire (Europe) | OTX-TKI maintained vision and CSFT comparable to aflibercept every eight weeks, with 89% reduction in treatment burden over a 12-month period OTX-TKI demonstrated no drug-related ocular or systemic... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 3.296 |
EVOTEC | 2.636 |
TUI | 2.075 |
NEL | 1.326 |
BAYER | 1.145 |
PLUG POWER | 1.142 |
NVIDIA | 1.135 |
RHEINMETALL | 1.060 |
AMC ENTERTAINMENT | 1.034 |
DEUTSCHE BANK | 959 |
SIEMENS ENERGY | 935 |
RENK GROUP | 874 |
REDCARE PHARMACY | 727 |
COMMERZBANK | 726 |
HEIDELBERGER DRUCK | 701 |
ALIBABA | 675 |
VOLKSWAGEN | 670 |
E.ON | 618 |
BARRICK GOLD | 612 |
BYD | 592 |
RWE | 585 |
SIEMENS | 564 |
TESLA | 562 |
DEUTSCHE LUFTHANSA | 560 |
AIXTRON SE | 554 |